RFC
ITCI

Regions Financial Corp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Regions Financial Corp’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,025
Closed -$336K – 841
2024
Q4 		$336K Sell
4,025
-40
-1% -$3.29K ﹤0.01% 659
2024
Q3 		$297K Sell
4,065
-55
-1% -$4.13K ﹤0.01% 711
2024
Q2 		$282K Sell
4,120
-115
-3% -$7.98K ﹤0.01% 703
2024
Q1 		$293K Sell
4,235
-156
-4% -$10.7K ﹤0.01% 717
2023
Q4 		$314K Sell
4,391
-96
-2% -$5.52K ﹤0.01% 692
2023
Q3 		$234K Buy
4,487
+550
+14% +$32K ﹤0.01% 733
2023
Q2 		$249K Buy
3,937
+123
+3% +$7.67K ﹤0.01% 735
2023
Q1 		$206K Buy
+3,814
New +$184K ﹤0.01% 779

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Regions Financial Corp's ITCI Position: Q1 2025 in Review

Regions Financial Corp sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 4,025 shares — an estimated $336K sold.

Regions Financial Corp first reported a position in ITCI in Q1 2023 and held it in 8 quarters. The position peaked at $336K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Regions Financial Corp reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Regions Financial Corp sold 4,025 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $336K.
  • Regions Financial Corp first reported a position in Intra-Cellular Therapies Inc. in Q1 2023 and held it in 8 quarters.
  • Regions Financial Corp's Intra-Cellular Therapies Inc. position peaked at $336K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Regions Financial Corp's 13F filing for Q1 2025, filed 8 May 2025.